BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2391682)

  • 1. Synthesis and antitumor activity of 9-[(carbamoyloxy)alkyl]anthracyclines: a novel class of anthracycline derivatives.
    Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
    J Med Chem; 1990 Sep; 33(9):2380-4. PubMed ID: 2391682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
    Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
    J Med Chem; 1990 Sep; 33(9):2375-9. PubMed ID: 2391681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of new anthracyclines.
    Florent JC; Genot A; Monneret C
    J Antibiot (Tokyo); 1989 Dec; 42(12):1823-30. PubMed ID: 2621164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of isodoxorubicin analogues.
    Florent JC; Gaudel G; Monneret C; Hoffmann D; Kraemer HP
    J Med Chem; 1993 May; 36(10):1364-8. PubMed ID: 8496904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    StefaƄska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensely potent morpholinyl anthracyclines.
    Acton EM; Tong GL; Mosher CW; Wolgemuth RL
    J Med Chem; 1984 May; 27(5):638-45. PubMed ID: 6716401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of anthracycline antibiotics IV. Synthesis of new anthracyclines with trisaccharide.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Ishikura T
    J Antibiot (Tokyo); 1982 Mar; 35(3):312-20. PubMed ID: 6951827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
    Mosher CW; Wu HY; Fujiwara AN; Acton EM
    J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New N-amino acid derivatives of daunorubicin.
    Dzieduszycka M; Stefanska B; Borowski E; Martelli S
    Farmaco Sci; 1986 Nov; 41(11):881-91. PubMed ID: 3803566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
    Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions.
    Yamamoto K; Acton EM; Henry DW
    J Med Chem; 1972 Aug; 15(8):872-5. PubMed ID: 5044313
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
    Rocherolle V; Olesker A; Lukacs G
    J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K; Takagi Y; Tsuchiya T
    Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.
    Israel M; Airey JE; Murray RJ; Gillard JW
    J Med Chem; 1982 Jan; 25(1):28-31. PubMed ID: 7086818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin analogues incorporating chemically reactive substituents.
    Farquhar D; Newman RA; Zuckerman JE; Andersson BS
    J Med Chem; 1991 Feb; 34(2):561-4. PubMed ID: 1995877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-salicylidene derivatives of pirarubicin.
    Ajito K; Ikeda D; Komuro K; Nosaka C; Wako N; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1133-44. PubMed ID: 2753818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geiparvarin analogues. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates.
    Simoni D; Manfredini S; Tabrizi MA; Bazzanini R; Baraldi PG; Balzarini J; De Clercq E
    J Med Chem; 1991 Nov; 34(11):3172-6. PubMed ID: 1956034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.